Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $8.14 USD
Change Today +0.51 / 6.68%
Volume 655.9K
CRMD On Other Exchanges
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

cormedix inc (CRMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/10/15 - $9.48
52 Week Low
05/27/14 - $1.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CORMEDIX INC (CRMD)

Related News

No related news articles were found.

cormedix inc (CRMD) Related Businessweek News

No Related Businessweek News Found

cormedix inc (CRMD) Details

CorMedix Inc., a pharmaceutical company, intends to in-license, develop, and commercialize therapeutic products for the prevention and treatment of cardiac, renal, and infectious diseases. The company markets Neutrolin, a catheter lock solution for the prevention of catheter related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, and central venous catheters used for vascular access in hemodialysis patients. Its product candidate is CRMD004, which is the gel formulation of Neutrolin intended for the treatment of wounds, skin infections, soft tissue infections, and the prevention of catheter exit site infections. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.

5 Employees
Last Reported Date: 03/12/15
Founded in 2006

cormedix inc (CRMD) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $287.5K
Co-Founder, Vice Chairman, Chief Scientific O...
Total Annual Compensation: $249.8K
Chief Financial Officer
Total Annual Compensation: $103.8K
Compensation as of Fiscal Year 2014.

cormedix inc (CRMD) Key Developments

CorMedix, Inc. Presents at 27th Annual ROTH Conference, Mar-10-2015 12:30 PM

CorMedix, Inc. Presents at 27th Annual ROTH Conference, Mar-10-2015 12:30 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States.

CorMedix, Inc. to Report Q4, 2014 Results on Mar 13, 2015

CorMedix, Inc. announced that they will report Q4, 2014 results at 4:00 PM, US Eastern Standard Time on Mar 13, 2015

CorMedix, Inc., Q4 2014 Earnings Call, Mar 13, 2015

CorMedix, Inc., Q4 2014 Earnings Call, Mar 13, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRMD:US $8.14 USD +0.51

CRMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CRMD.
View Industry Companies

Industry Analysis


Industry Average

Valuation CRMD Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CORMEDIX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at